Baxter
BAX
26,26 €
Share price
-8.17%
Change (1 day)
-33.16%
Change (1 year)
Categories
Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.
Baxter (BAX) - Total assets
Total assets on the balance sheet as of December 2024 : €23.51 Billion
According to Baxter's latest financial reports the company's total assets are €23.51 Billion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Baxter - Total assets on balance sheet (from 2001 to 2024)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2024-12-31 | €24.77 B | -3.14% |
| 2023-12-31 | €25.57 B | -3% |
| 2022-12-31 | €26.37 B | -10.91% |
| 2021-12-31 | €29.59 B | 81.86% |
| 2020-12-31 | €16.27 B | 0.22% |
| 2019-12-31 | €16.24 B | 18.19% |
| 2018-12-31 | €13.74 B | -3.64% |
| 2017-12-31 | €14.26 B | -3.51% |
| 2016-12-31 | €14.77 B | -22.91% |
| 2015-12-31 | €19.17 B | -10.8% |
| 2014-12-31 | €21.49 B | 17.66% |
| 2013-12-31 | €18.26 B | 18.49% |
| 2012-12-31 | €15.41 B | 4.96% |
| 2011-12-31 | €14.68 B | 11.7% |
| 2010-12-31 | €13.14 B | 8.55% |
| 2009-12-31 | €12.11 B | 9.92% |
| 2008-12-31 | €11.01 B | 5.2% |
| 2007-12-31 | €10.47 B | -5.89% |
| 2006-12-31 | €11.12 B | 3.6% |
| 2005-12-31 | €10.74 B | 3.02% |
| 2004-12-31 | €10.42 B | -4.21% |
| 2003-12-31 | €10.88 B | -8.79% |
| 2002-12-31 | €11.93 B | 1.92% |
| 2001-12-31 | €11.71 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 | €42.87 B | 82.31% | 🇺🇸 USA |
 | €39.19 B | 66.67% | 🇺🇸 USA |
 | €35.93 B | 52.80% | 🇺🇸 USA |
 | €49.86 B | 112.03% | 🇺🇸 USA |
 | €1.88 B | -92.00% | 🇺🇸 USA |
 | €88.77 B | 277.48% | 🇺🇸 USA |
 | N/A | N/A | 🇺🇸 USA |
 | €4.24 B | -81.94% | 🇺🇸 USA |
 | €82.07 B | 248.98% | 🇮🇪 Ireland |
 | €3.83 B | -83.69% | 🇺🇸 USA |